Claims:WE CLAIMS
1. A handheld nebulizer device (100) comprising:
a main unit(102) having top end (104) with plurality of slots (106), bottom end (108), side portions (110), front portion (112) and back portion (114);
a power source replaceably housed within the main unit (102);
plurality of electrodes (116) placed at the top end (104) of the main unit (102);
a connector (118) suitably provided on either of the side portion (110) of the main unit (102);
a push button (120) suitably provided on the front portion (112) of the main unit (102);
an indicator (122) suitably provided on the front portion (112) of the main unit (102);
a discharge unit (124) having first end (126) with protrusions (128) and second end (130) with external threads, wherein the protrusions(128) are removablyfitted in the slots(106) of the top end (104) of the main unit (102),
wherein, the discharge unit (124) comprises
a cap (132) having inner threads removablyfittedon the external threads of the second end (130) of the discharge unit (124),
a reservoir (134) for holding a pharmaceutical composition accessible by removing the cap (132),
an outlet (136) for releasing a nebulized pharmaceutical composition,
a disk (138) with multiple holes arranged at an entrance of the outlet (136) and placed between the reservoir (134) and the outlet (136), wherein the disk (138) is configured to be in continuous contact with the pharmaceutical composition, to nebulize, till the reservoir (134) gets empty,
a gasket (140) placed around the disk (138) and configured to avoid the leakage,
a vibrating element suitably in communication with the power source through the electrodes(116) and configured to vibrate the disk (138);
wherein, the push button (120) is configured to activate and toggle between various modes of nebulization based upon an operator’s requirement and the indicator (122) is configured to trigger appropriately according to the various modes of nebulization.
2. The handheld nebulizer device (100) according to claim 1, wherein the main unit (102) and the discharge unit (124) are removably attached with snap fitting arrangement.
3. The handheld nebulizer device (100) according to claim 1, wherein the connector (118) is an USB slot, where an USB cable is connected to 5V 1A power supply to recharge the nebulizer device(100).
4. The handheld nebulizer device (100) according to claim 1, wherein the indicator (122) is a visual indicator, where it glows different lights appropriately at particular event.
5. The handheld nebulizer device (100) according to claim 1, wherein the reservoir (134) holds the pharmaceutical composition preferably LifeViroTreat.
6. The handheld nebulizer device (100) according to claim 1, wherein the reservoir (134) is designed considering the pharmaceutical composition preferably LifeViroTreat.
7. The handheld nebulizer device (100) according to claim 1, wherein the disk (138)with multiple holes are plurality of micrometric nebulization holes of 4-5 microns in order to create low velocity aerosol.
8. The handheld nebulizer device (100) according to claim 1, wherein the various modes of nebulization comprises larger flow rate and smaller flow rate of nebulized pharmaceutical composition.
9. A portable nebulizer device (200) comprises:
a housing (210);
an air compressor (212);
a motor (214) connected to the air compressor (212) and configured to drive the air compressor (212);
a power cable (216) connected to an external power source to provide required working voltage to the motor (214);
a power button (218) mounted in the housing (210) and electrically connected between the motor (214) and the power cable (216), wherein the power button (218) extended to the outside of the housing (210) for operation by the operator to turn on/off said motor;
a nebulizer reservoir (220) configured to hold a pharmaceutical composition;
an aerosol tubing (222) connected between the air compressor (212) and the nebulizer reservoir (220) and configured to carry a compressed air from the air compressor (212) to the nebulizer reservoir (220) to nebulize the pharmaceutical composition;
wherein, the power button (218) is configured to activate and toggle between various modes of nebulization based upon an operator’s requirement.
10. The portable nebulizer device (200) according to claim 9, wherein air compressor (212) is designed as a piston compressor.
11. The portable nebulizer device (200) according to claim 9, wherein the nebulizer reservoir (220) holds the pharmaceutical composition preferably LifeViroTreat.
12. The portable nebulizer device (200) according to claim 9, wherein nebulizer reservoir (220) is designed considering the pharmaceutical composition preferably LifeViroTreat.
13. The portable nebulizer device (200) according to claim 1, wherein the various modes of nebulization comprises larger flow rate and smaller flow rate of nebulized pharmaceutical composition.
, Description:BRIEF DESCRIPTION OF THE DRAWINGS
The following figures are illustrative of particular examples for enabling embodiments of devices and methods of the present disclosure, are descriptive of some of the embodiments and are not intended to limit the scope of the disclosure. The figures are not to scale (unless so stated) and are intended for use in conjunction with the explanations in the following detailed description. Wherever applicable, the words and phrases used herein should be understood and interpreted to have a meaning consistent with the understanding of those words and phrases by those skilled in the relevant art. Persons skilled in the art will appreciate that elements in the figures are illustrated for simplicity and clarity and may have not been drawn to scale. For example, the dimensions of some of the elements in the figure may be exaggerated relative to other elements to help to improve understanding of various exemplary embodiments of the present disclosure. Throughout the drawings, it should be noted that like reference numbers are used to depict the same or similar elements, features, and structures.
Figure 1 illustrates aside view of the nebulizer device according to the present disclosure.
Figure 2 illustrates a perspective view of the nebulizer device with a discharge unit in removed position.
Figure 3 illustrates a side view of the nebulizer device as a physical product/LIFEACTIVUS K999™.
Figure 4illustrates a perspective view of another embodiment of an air compressor nebulizer device/LIFEACTIVUS K1000™.
DETAILED DESCRIPTION
In the description that follows, a number of terms are used, the following definitions are provided to facilitate understanding of various aspects of the disclosure. Use of examples in the specification, including examples of terms, is for illustrative purposes only and is not intended to limit the scope and meaning of the embodiments of the invention herein. Numeric ranges are inclusive of the numbers defining the range. In the specification, the word “comprising” is used as an open-ended term, substantially equivalent to the phrase “including, but not limited to,” and the word “comprises” has a corresponding meaning.
The terms and words used in the following description are not limited to the bibliographical meanings, but, are merely used to enable a clear and consistent understanding of the disclosure. Accordingly, it should be apparent to those skilled in the art that the following description of exemplary embodiments of the present disclosure are provided for illustration purpose only and not for the purpose of limiting the disclosure as defined by the appended claims and their equivalents.
Features that are described and/or illustrated with respect to one embodiment may be used in the same way or in a similar way in one or more other embodiments and/or in combination with or instead of the features of the other embodiments.
Accordingly, the term “pharmaceutical composition” used herein is for treating or preventing respiratory viral infection associated with an upper respiratory condition, or lower respiratory tract infection including lung tissue. The pharmaceutical composition is in the form of liquid, solution, suspension and emulsion. Numerous inhalation delivery systems have been developed and studied to treat respiratory viral infection. All are encompassed in the scope of present invention.
Referring now to Fig. 1 and 2, there is shown the nebulizer device100.
The nebulizer device100, which uses the vibrating mesh technology, is in particular of the handheld type. The nebulizer device100 is manufactured with particular dimensions and weight such that it gives an advantage of on the go usage other than a domestic and/or hospital environment.
The nebulizer device100 comprises a main unit 102. The main unit 102 includes top end 104 and bottom end 108. The top end 104 of the main unit 100 possesses plurality of slots 106. Further, the main unit 102 includes side portions 110, front portion 112 and back portion 114. The main unit 102 is designed in such a way that it can be easily gripped. The main unit 102may be shaped as cylindrical or any such similar shape.
The main unit 102 comprises internally electronic and electrical components of the device, not shown in the figures. The electronic and electrical components includes electrical wiring, plurality of electrodes 116 coming out from the top end 104 of the main unit 102. Further, the main unit 102 internally houses a power source, not shown, within it. The power source comprises batteries, preferably lithium batteries. These lithium batteries are rechargeable batteries. The main unit 102 further comprises an externally accessible control interface which consists of a push button 120 suitably provided on the front portion 112 of the main unit 102. Furthermore, the main unit 102 externally consists of a connector 118 suitably provided on either of the side portion 110 of the main unit 102. The connector 118 is an USB slot, where an USB cable is connected to 5V 1A power supply to recharge the nebulizer device100. The connector 118 may be USB-A, USB-B, USB-C, USB-3.0, Mini-USB or Micro-USB etc. The external front portion 112 of the main unit 102 also includes an indicator 122 suitably provided in the proximity of the push button 120. The indicator 122 is a visual indicator, where it glows different lights appropriately at particular event. The indicator 122 emits blue and/or green light appropriately at particular event.
Further, the nebulizer device100 comprises a discharge unit 124. The discharge unit 124 includes first end 126 and second end 130.The first end 126 is provided with protrusions 128 pointing towards bottom side of the nebulizer device100. The protrusions 128 are configured to removably fit in the slots 106 of the top end 104 of the main unit 102. The main unit 102 and the discharge unit 124 are removably attached by snap-fitting arrangement. The main unit 102 and the discharge unit 124 may detachably attached by other similar joints. The second end 130 is provided with external threads. Further, the discharge unit 124 includes a cap 132. The cap 132is provided with inner threads and is configured to removably fit on the external threads of the second end 130 of the discharge unit 124. A tight fitting of the cap due to threads provides brings leak proof feature to the nebulizer device100. The discharge unit houses a reservoir 134.The reservoir 134 is configured to hold a pharmaceutical composition which is accessible by removing the cap 132. The reservoir 134 is configured to hold the pharmaceutical composition preferably LifeViroTreat. The reservoir 134 is designed considering the pharmaceutical composition preferably LifeViroTreat. The reservoir 134 is provided with markings on an outer surface to measure the intake of pharmaceutical composition. The capacity of the reservoir 134 is 20 ml and can accommodate up to 10-15 ml of the pharmaceutical composition.
Furthermore, the discharge unit 124 include an outlet 136 which is configured to release a nebulized pharmaceutical composition, a disk 138 with multiple holes arranged at an entrance of the outlet 136 and placed between the reservoir 134 and the outlet 136. The disk 138 is configured to be in continuous contact with the pharmaceutical composition, to nebulize, till the reservoir 134 gets empty. This provides advantage of less or no residue of the pharmaceutical composition. Also, this offers fewer efforts in rinsing the reservoir 134 after usage. The disk 138 is provided by the gasket 140 on its surrounding. The gasket 140 may be made up of silicon rubber or any such material to avoid the leakage of the nebulized pharmaceutical composition. The process of nebulization is carried out by vibrating the disk 138 and the disk is vibrated with a vibrating element. The vibrating element is configured to suitably in communication with the power source through the electrodes 116.
In operations, the nebulizer device100 is turned on by pressing and holding the push button 120 for 3 seconds. The turning on of the nebulizer device100 is also confirmed by the indicator 122, which shows blue light at this moment. The blue light also indicates larger flow rate of the nebulized pharmaceutical composition. It means when the device 100 is turned on, there is by default larger low rate. Again, the push button 120 is pressed to change the flow to slow. At this moment, the slower flow rate is confirmed by lighting of blue and green light alternatively. In the larger flow rate mode, the nebulized pharmaceutical composition is released from the outlet 136 at about < 4 ml/min. Also, in the smaller flow rate mode, the nebulized pharmaceutical composition is released from the outlet 136 at about > 4 ml/min. In this way, the push button 120 is used to activate and toggle between larger and slower mode of nebulization based upon an operator’s requirement on the device 100 itself. Also, the indicator 122 helps to identify the activation of the above said modes of nebulization. Further, the indicator 122 helps to identify ‘low battery’ by flashing and turning off the blue light, the ‘charging mode’ by flickering the blue light, ‘complete charge’ by green light.
Fig. 3 shows the nebulizer device as a physical product. As shown in Fig. 3, the nebulizer device is handheld and easy to use device. It enhances an user experience as it is very easy to use and easy to maintain.
Fig. 4 shows another embodiment of the nebulizer device200. The nebulizer device200comprises a housing 210 and an air compressor 212. The air compressor 212is designed as a piston compressor. The air compressor 212 is connected to a motor 214 and is drive by the motor 214. The motor 214 draws required working voltage from an external power source connected through power cable 216. The motor 214 and the power cable 216 are electrically connected via a power button 218 and mounted in the housing 210. The power button 218 extended to the outside of the housing 210 for operation by the operator to turn on/off said motor.
Further, the nebulizer device200 comprises a nebulizer reservoir 220, which is configured to hold pharmaceutical composition. The nebulizer reservoir 220 holds the pharmaceutical composition preferably LifeViroTreat. Also, the nebulizer reservoir 220 is designed considering the pharmaceutical composition preferably LifeViroTreat. Furthermore, an aerosol tubing 222 is connected between the air compressor 212 and the nebulizer reservoir 220. The aerosol tubing 222 is configured to carry a compressed air from the air compressor 212to the nebulizer reservoir 220 to nebulize the pharmaceutical composition. The power button 218 is configured to activate and toggle between various modes of nebulization based upon an operator’s requirement.
In operations, the nebulizer device200gets activated by pressing the power button 218 to drive the motor 214. A fan is coupled to the motor 214 and rotates with the motor 214 to cause currents of air for dissipation of heat during operation of the motor 214 and the air compressor 212.As soon as, the motor 214 starts, it moves the piston of the air compressor 212 in back and forth direction to generate the compressed air. This compressed air is carried by the aerosol tubing 222 towards the nebulizer reservoir 220, which is configured to hold pharmaceutical composition. Therefore, the pharmaceutical composition is turned into a fine mist for enabling the mist pharmaceutical composition to be deeply inhaled into the airways and lungs of a person. The power button 218 is used to activate and toggle between larger and slower mode of nebulization based upon an operator’s requirement on the device 200 itself. In the larger flow rate mode, the nebulized pharmaceutical composition is released at about < 4 ml/min. Also, in the smaller flow rate mode, the nebulized pharmaceutical composition is released at about > 4 ml/min.